Develops a structural nanomedicine platform to co-deliver optimized combinations of genetic and peptide payloads to target cells.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Flashpoint Therapeutics develops an advanced structural nanomedicine and biotechnology platform engineered to create a new class of high-potency cancer immunotherapies. The technology utilizes spherical nucleic acid structures to precisely co-deliver controlled ratios of RNA, peptide, and gene editing payloads directly to targeted immune cells and diseased tissue.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Flashpoint Therapeutics Management Team
Flashpoint Therapeutics Valuations & Financials
View real-time NPM data on Flashpoint Therapeutics stock including daily Flashpoint Therapeutics stock price estimates, valuation history, and historical share price information. Access Flashpoint Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Flashpoint Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Flashpoint Therapeutics? Get in touch to learn more.
Similar Companies
like Flashpoint Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
CloudKitchens
Consumer
Develops and operates real estate facilities for ghost kitchens and delivery-focused food businesses, providing tech-enabled kitchen spaces.
Coefficient
Enterprise Software
A no-code platform that integrates spreadsheets with business systems, Coefficient enables real-time data access and automation.
Alva Energy
Rapidly expands clean power by productizing uprates to increase output at existing reactors.
Unchained Capital
Web3 & Digital Assets
Provides collaborative custody multi-signature vaults and loans, enabling bitcoin holders to securely manage their assets.
Corcentric
Enterprise Software
A global provider of procurement and finance solutions, offering software, managed services, and strategic advisory to optimize financial operations.
Aurelius
Delivers artificial intelligence software and directed energy systems to automate autonomous counter-drone threat detection and elimination.
FAQ
We have answers
Flashpoint Therapeutics stock does not trade on public stock exchanges. Flashpoint Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Flashpoint Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Flashpoint Therapeutics Stock does not trade on public stock exchanges. In order to sell Flashpoint Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Flashpoint Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Flashpoint Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Flashpoint Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Flashpoint Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Flashpoint Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Flashpoint Therapeutics is a private company and has not had an IPO. There is currently no Flashpoint Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Flashpoint Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
